Hemodynamic effects of milrinone during weaning from cardiopulmonary bypass: Comparison of patients with a low and high prebypass cardiac index

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 14, Issue 4, 2000, Pages 367-373

  Yamada, Tatsuya ^a   Takeda, Junzo ^a   Katori, Nobuyuki ^a   Tsuzaki, Koichi ^a   Ochiai, Ryoichi ^a  

^a KEIO UNIVERSITY   (Japan)

Author keywords

Cardiac surgery; Cardiopulmonary bypass; Catecholamines; Inotropes; Milrinone

Indexed keywords

ADRENALIN; DOBUTAMINE; DOPAMINE; MILRINONE; NORADRENALIN; PLACEBO;

ADULT; AGED; ARTICLE; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; DRUG EFFICACY; FEMALE; HEART FUNCTION; HEART INDEX; HEMODYNAMICS; HUMAN; MALE; MYOCARDIAL DISEASE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SYSTEMIC VASCULAR RESISTANCE;

EID: 0033900401     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2000.7920     Document Type: Article

References (21)

1. Pharmacology of bipyridine phosphodiesterase III inhibitors
2. Pharmacology, mechanisms of action and uses of selective phosphodiesterase inhibitors
3. Efficacy and safety of sustained (48 hour) intravenous infusion of milrinone in patients with severe congestive heart failure: A multicenter study
4. Effects of twenty-four-hour milrinone infusion in patients with severe heart failure and cardiogenic shock as a function of the hemodynamic initial condition
5. The use of intravenous milrinone in chronic symptomatic ischemic heart disease
6. Pharmacokinetics and pharmacodynamics of milrinone in chronic congestive heart failure
7. Milrinone in the treatment of low output states following cardiac surgery
8. Haemodynamic and biological effects of intravenous milrinone in patients with a low cardiac output syndrome following cardiac surgery: Multicenter study
9. Overview of the effects of intravenous milrinone in acute heart failure following surgery
10. Intravenous milrinone following cardiac surgery: I. Effects of bolus infusion followed by variable dose maintenance infusion
11. Intravenous milrinone following cardiac surgery: II. Influence of baseline hemodynamics and patient factors on therapeutic response
12. A placebo-controlled trial verifying the efficacy of milrinone in weaning high-risk patients from cardiopulmonary bypass
13. The effect of milrinone on hemodynamics and left ventricular function after emergence from cardiopulmonary bypass
14. A pharmacokinetic and pharmacodynamic evaluation of milrinone in adults undergoing cardiac surgery
15. Comparison of two different loading doses of milrinone for weaning from cardiopulmonary bypass
16. Open-heart surgery in octogenarians
17. Decreased catecholamine sensitivity and beta-adrenergic-receptor density in failing human hearts
18. Cardiovascular effects of milrinone
19. Phosphodiesterase III inhibition or adrenoreceptor stimulation: Milrinone as an alternative to dobutamine in the treatment of severe heart failure
20. Pharmacokinetics of intravenous milrinone in patients undergoing cardiac surgery
21. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure: Dose-response relationships and comparison to nitroprusside